Cargando…
Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)
TP53 mutant head and neck squamous cell carcinoma (HNSCC) patients exhibit poor clinical outcomes with 50–60% recurrence rates in advanced stage patients. In a recent phase II clinical trial, adjuvant therapy with everolimus (mTOR inhibitor) significantly increased 2-year progression-free survival i...
Autores principales: | Alam, Md Maksudul, Fermin, Janmaris Marin, Knackstedt, Mark, Noonan, Mackenzie J., Powell, Taylor, Goodreau, Landon, Daniel, Emily K., Rong, Xiaohua, Moore-Medlin, Tara, Khandelwal, Alok R., Nathan, Cherie-Ann O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901561/ https://www.ncbi.nlm.nih.gov/pubmed/36745547 http://dx.doi.org/10.18632/oncotarget.28355 |
Ejemplares similares
-
Comparing cell‐free circulating tumor DNA mutational profiles of disease‐free and nonresponders patients with oropharyngeal squamous cell carcinoma
por: Khandelwal, Alok R., et al.
Publicado: (2020) -
Thromboxane prostanoid signaling in macrophages attenuates lymphedema and facilitates lymphangiogenesis in mice: TP signaling and lymphangiogenesis
por: Mishima, Toshiaki, et al.
Publicado: (2023) -
C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α
por: Min, Yongfen, et al.
Publicado: (2011) -
The novel oncogenic factor TET3 combines with AHR to promote thyroid cancer lymphangiogenesis via the HIF-1α/VEGF signaling pathway
por: Yang, Liyun, et al.
Publicado: (2023) -
Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D
por: Zhu, Chenfang, et al.
Publicado: (2016)